Nibourel O, Guihard S, Roumier C, Pottier Letter, Terre C, Paquet Good, Peyrouze P, Geffroy S, Quentin S, Alberdi An excellent, Abdelali RB, Renneville A good, Demay C, Celli-Lebras K, Barbry P, Quesnel B, Castaigne S, Dombret H, Soulier J, Preudhomme C, Cheok MH. Copy-number data understood brand new prognostic ;31(3):555-564.

Mohamed Was, Balsat Yards, Koering C, Maucort-Boulch D, Boissel Letter, Payen-Homosexual L, Cheok Meters, Mortada H, Auboeuf D, Pinatel C, El-Hamri Meters, Tigaud I, Hayette S, Dumontet C, Cros E, Flandrin-Gresta P, Nibourel O, Preudhomme C, Thomas X, Nicolini FE, Solly F, Guyotat D, Campos L, Michallet Meters, Ceraulo A beneficial, Mortreux F, Wattel E. Leuk Res. 2017;-twenty eight.

Mishima Y, Paiva B, Shi J, Park J, Manier S, Takagi S, Massoud M, Perilla-Glen A great, Aljawai Y, Huynh D, Roccaro Are, Sacco Good, Capelletti Yards, Detappe A, Alignani D, Anderson KC, Munshi NC, Do well F, Lohr JG, Ha Grams, Freeman SS, Van Allen EM, Adalsteinsson Virtual assistant, Michor F, San Miguel JF, Ghobrial Im. 2017;19(1):218-224.

Minnema MC, Kimby Age, DSa S, Fornecker LM, Poulain S, Snijders TJ, Kastritis Age, Kremer S, Fitsiori A good, Simon L, Davi F, Lunn M, Castillo JJ, Patterson CJ, Ce Garff-Tavernier Meters, Costopoulos M, Leblond V, Kersten MJ, Dimopoulos MA, Treon SP. Guideline for the medical diagnosis, treatment and you will impulse criteria getting Bing-Neel disorder. Haematologica. 2017;102(1):43-51.

Micol JB, Pastore A beneficial, Inoue D, Duployez Letter, Kim Age, Lee South carolina, Durham BH, Chung Year, Cho H, Zhang XJ, Yoshimi An effective, Krivtsov An excellent, Koche R, Solary Elizabeth, Sinha A beneficial, Preudhomme C, Abdel-Wahab O. ASXL2 is essential to own haematopoiesis and you will will act as a great haploinsufficient tumour suppressor when you look at the leukemia. Nat Commun. 2017;8:15429.

Telephone Associate

Meunier Yards, Ancelet S, Lefebvre C, Arnaud J, Garrel C, Pezet Meters, Wang Y, Faure P, Szymanski G, Duployez Letter, Preudhomme C, Biard D, Polack B, Cahn JY, Moulis JM, Park S. Activated outdoors species accounts control NF-kappaB activation because of the lower dose deferasirox into the erythroid progenitors away from reduced risk myelodysplastic syndromes. Oncotarget. 2017;8(62):105510-105524.

Manier S, Salem KZ, Park J, Landau Weil, Getz Grams, Ghobrial I will be. Genomic complexity regarding multiple myeloma and its particular scientific implications. Nat Rev Clin Oncol. 2017;14(2):100-113.

Manier S, Efforts JT, Sacco An effective, Glavey SV, Huynh D, Reagan MR, Salem KZ, Moschetta Meters, Shi J, Mishima Y, Roche-Lestienne C, Leleu X, Roccaro In the morning, Daley GQ, Ghobrial I’m. This new LIN28B/let-seven axis was a novel healing pathway for the multiple myeloma. Leukemia. 2017;31(4):853-860.

Manier S, Liu CJ, Avet-Loiseau H, Playground J, Shi J, Campigotto F, Salem KZ, Huynh D, Glavey SV, Rivotto B, Sacco An effective, Roccaro Was, Bouyssou J, Minvielle S, Moreau P, Facon T, Leleu X, Weller Age, Trippa L, Ghobrial I am. Prognostic role regarding circulating exosomal miRNAs inside the numerous myeloma. Blood. 2017;129(17):2429-2436.

TET2 exon dos missing are a separate beneficial prognostic basis for cytogenetically regular serious myelogenous leukemia (AML): TET2 exon 2 missing inside the AML

Manier S, Huynh D, Shen YJ, Zhou J, Yusufzai T, Salem KZ, Ebright RY, Shi J, Park J, Glavey SV, Devine WG, Liu CJ, Leleu X, Quesnel B, Roche-Lestienne C, Snyder JK, Brown Le, Gray Letter, Bradner J, Whitesell L, Porco JA, Jr., Ghobrial I will be. Suppressing the brand new oncogenic translation program is an efficient therapeutic means in numerous myeloma. Sci Transl Med. 2017;9(389).

Magnez R, Thiroux B, Taront S, Segaoula Z, Quesnel B, Thuru X. PD-1/PD-L1 binding training having fun with microscale thermophoresis. Sci Representative. 2017;7(1):17623.

Lacombe F, Campos L, Allou K, Arnoulet C, Delabarthe A good, Dumezy F, Feuillard J, Genevieve F, Guerin Age, Guy J, Jouault H, Lepelley P, Maynadie Yards, Solly F, Ballon OW, Preudhomme C, Baruchel A beneficial, Dombret H, Ifrah N, Bene MC. datemyage Prognostic value of multicenter circulate cytometry matched up testing off restricted residual situation inside intense myeloblastic leukemia. Hematol Oncol. 2017.